Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Novanta
NOVT
$5.04B
| $36.3M | 0.03% |
385,400
-90,000
| -19% | -$7.68M |
|
627
US Foods
USFD
$22.3B
| $36.3M | 0.03% |
1,016,300
+327,600
| +48% | +$11.9M |
|
628
Simply Good Foods
SMPL
$941M
| $36.3M | 0.03% |
1,509,000
-178,800
| -11% | -$4.05M |
|
629
Onto Innovation
ONTO
$12B
| $36.3M | 0.03% |
1,046,300
+7,090
| +0.7% | +$227K |
|
|
WBK
630
DELISTED
Westpac Banking Corporation
WBK
| $36.3M | 0.03% |
1,820,600
+199,800
| +12% | +$3.83M |
|
|
ALX
631
Alexander's
ALX
$1.36B
| $36.3M | 0.03% |
97,964
+10,500
| +12% | +$3.99M |
|
|
EBSB
632
DELISTED
Meridian Bancorp, Inc.
EBSB
| $36.2M | 0.03% |
2,024,444
-29,014
| -1% | -$496K |
|
633
Howmet Aerospace
HWM
$114B
| $36.1M | 0.03% |
1,825,339
+1,493,993
| +451% | +$25.2M |
|
634
FNB Corp
FNB
$6.81B
| $36.1M | 0.03% |
3,067,328
+1,205,501
| +65% | +$13.9M |
|
|
ZIXI
635
DELISTED
Zix Corporation
ZIXI
| $36M | 0.03% |
3,957,800
-232,005
| -6% | -$2.02M |
|
636
Safety Insurance
SAFT
$1.51B
| $35.8M | 0.03% |
376,186
-19,814
| -5% | -$1.84M |
|
637
Boston Properties
BXP
$11.2B
| $35.8M | 0.03% |
277,400
-30,900
| -10% | -$4.15M |
|
638
Suzano
SUZ
$10.4B
| $35.8M | 0.03% |
4,200,038
-10,600
| -0.3% | -$102K |
|
|
JOYY
639
JOYY Inc
JOYY
$3.77B
| $35.7M | 0.03% |
512,600
+224,800
| +78% | +$17.1M |
|
|
NAV
640
DELISTED
Navistar International
NAV
| $35.7M | 0.03% |
1,035,300
+238,500
| +30% | +$7.92M |
|
641
Regis Corp
RGS
$68.2M
| $35.6M | 0.03% |
107,290
+3,650
| +4% | +$1.38M |
|
|
MNR
642
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $35.5M | 0.03% |
2,616,303
+92,502
| +4% | +$1.27M |
|
643
Qorvo
QRVO
$8.09B
| $35.3M | 0.03% |
529,306
+467,406
| +755% | +$32.5M |
|
644
WesBanco
WSBC
$4.03B
| $35.3M | 0.03% |
914,564
+57,887
| +7% | +$2.23M |
|
|
PRA
645
DELISTED
ProAssurance
PRA
| $35.2M | 0.03% |
974,100
+190,100
| +24% | +$7.07M |
|
|
VIVO
646
DELISTED
Meridian Bioscience Inc
VIVO
| $35.1M | 0.03% |
2,953,000
-51,048
| -2% | -$615K |
|
647
Kroger
KR
$36.3B
| $35.1M | 0.03% |
+1,615,100
| New | +$39.3M |
|
648
Sempra
SRE
$59.2B
| $35M | 0.03% |
509,860
-304,740
| -37% | -$20M |
|
|
ORIT
649
DELISTED
Oritani Financial Corp. New
ORIT
| $35M | 0.03% |
1,972,000
-18,800
| -0.9% | -$314K |
|
|
ACOR
650
DELISTED
Acorda Therapeutics
ACOR
| $35M | 0.03% |
37,983
+4,555
| +14% | +$5.6M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.